亚洲134丁香五月天,久久这里都是青草伊人91,国产精品二区在线观看,亚洲无码一区在又爽又色在线视频

首頁 >> 產品展示 >> 分子生物學 >> invitrogen試劑代購 >> 12587010B-27 SUPPLEMENT Invitrogen現貨

B-27 SUPPLEMENT Invitrogen現貨

簡要描述:B-27 SUPPLEMENT Invitrogen現貨
相關產品:
LightShift 化學發光EMSA試劑盒
微型BCA蛋白定量分析試劑盒
SuperSignal West Pico化學發光底物
A variation of the most cited neuronal cell culture supplement, B-27 Supplement Minus Vitamin

  • 產品型號:12587010
  • 廠商性質:經銷商
  • 更新時間:2018-02-09
  • 訪  問  量:1187
詳細資料

B-27 SUPPLEMENT  Invitrogen現貨

  / 4000-520-616/

B-27 SUPPLEMENT  Invitrogen現貨

 

B-27 SUPPLEMENT  Invitrogen現貨

 

描述

相關產品:
LightShift 化學發光EMSA試劑盒
微型BCA蛋白定量分析試劑盒
SuperSignal West Pico化學發光底物
A variation of the most cited neuronal cell culture supplement, B-27 Supplement Minus Vitamin A is a customized version of the original B-27 Supplement without vitamin A (retinyl acetate). B-27 Supplement Minus Vitamin A is a serum-free supplement ideal for the c*tion of neural progenitor and stem cells, either as neurospheres in suspension or in adherent monolayer culture, without inducing differentiation. B-27 Supplement Minus Vitamin A is provided as a 50X liquid and is intended for use with Neurobasal Medium or Neurobasal-A Medium for neuronal cell culture without the need for an astrocyte feeder layer.

B-27 Supplement is suitable for use in most neuronal cell applications. For other applications, we provide alternative formulations of B-27 Supplement and Neurobasal media.

For established protocols using B-27 Supplement, access our Gibco Neurobiology Protocol Handbook.

View publications using Gibco neurobiology products at our Gibco CellCite.


 



 

 

B-27 SUPPLEMENT  Invitrogen現貨

B-27 SUPPLEMENT  Invitrogen現貨

 

如果你對12587010B-27 SUPPLEMENT Invitrogen現貨感興趣,想了解更詳細的產品信息,填寫下表直接與廠家聯系:

留言框

  • 產品:

  • 您的單位:

  • 您的姓名:

  • 聯系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結果(填寫阿拉伯數字),如:三加四=7

蘇州螞蟻淘生物科技有限公司(m.myhrw.cn)主營產品:海外生命科學試劑儀器代購

總訪問量:243677  管理登陸  技術支持:化工儀器網  sitemap.xml

版權所有 © 2024 蘇州螞蟻淘生物科技有限公司  ICP備案號:蘇ICP備17049038號-2
在線留言 聯系方式 二維碼

服務熱線

18915418616

掃一掃,關注我們